Skip to main content
    S

    Senti Biosciences Inc (SNTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.14
    -0.00 (-2.86%)

    Market Cap: $5.38M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Senti Biosciences Inc (SNTI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Senti Biosciences (SNTI) to earn -$1.05 per share in the fiscal year ending Dec 31, 2026, on revenue of $50000. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.95.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates are unchanged.

    Fiscal year ending Dec 31, 2026
    -$1.05
    EPS consensus, revenue $50000
    Fiscal year ending Dec 31, 2027
    -$0.95
    EPS consensus, revenue $50000
    Next report
    Mar 22, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.05-$1.31 to -$0.782$50000N/A2
    Dec 31, 2027-$0.95-$0.96 to -$0.942$50000N/A2

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.33-$0.43 to -$0.224

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.09.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.05-$1.16-$1.16-$1.16-$1.09N/A
    Fiscal year ending Dec 31, 2027-$0.95-$0.95-$0.95-$0.95-$0.90N/A

    Frequently Asked Questions About SNTI

    What is the SNTI stock forecast?

    Consensus analyst estimates put Senti Biosciences's EPS at -$1.05 for the fiscal year ending Dec 31, 2026, on revenue of $50000.

    What EPS do analysts expect from SNTI next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.05, with estimates from -$1.31 to -$0.78 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.95, with estimates from -$0.96 to -$0.94 from 2 analysts.

    What revenue do analysts expect from Senti Biosciences next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $50000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $50000.

    How many analysts cover SNTI?

    2 analysts estimate EPS for Senti Biosciences for the fiscal year ending Dec 31, 2026.